Evidence map›Paper›PMID 32670374›Full record

ArticleInternational journal of analytical chemistry2020

Comprehensive Screening and Identification of Phillyrin Metabolites in Rats Based on UHPLC-Q-Exactive Mass Spectrometry Combined with Multi-Channel Data Mining.

Beibei Ma, Jiameng Li, Tianyu Lou, Yaoyue Liang, Chenxiao Wang, Ruiji Li, Tingting Wang, Jinhui Liu, Yudong Guo, Zhibin Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of analytical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Beibei MaSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-4235-0792
Jiameng LiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
Tianyu LouSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
Yaoyue LiangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
Chenxiao WangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
Ruiji LiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
Tingting WangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
Jinhui LiuSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.
Yudong GuoBeijing Institute for Drug Control, Beijing, China.
Zhibin WangBeijing Research Institution of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0003-3091-0921
Jing WangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0001-5201-8323
Beijing University of Chinese Medicine · CNBeijing Center for Disease Prevention and Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phillyrin, a well-known bisepoxylignan, has been shown to have many critical pharmacological activities. In this study, a novel strategy for the extensive acquisition and use of data was established based on UHPLC-Q-Exactive mass spectrometry to analyze and identify the

Identifiers

PMID32670374
PMCPMC7333037
OpenAlexW3037922134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.